High-dose versus low-dose betahistine for vertigo attacks in unilateral Meniere's disease

Randomised trial of betahistine in Meniere Disease (2 arms), sponsored by Prof. Dr. P.P.G. van Benthem (November 2015) Functie/ Position: Hoogleraar Keel-, neus-, oorheelkunde │Opleiding/Education: Studierichting/ Subject: T: +31 55 844 8207 │ F: +31 55 581 8194 │E: [email protected] Prof. Dr. P.P.G. van Benthem (november 2015) University Medical Centre Leiden Head Otorhinolaryngolgy and Head- and Neck Surgery P.O. Box 9600 2300 RC Leiden. Primary endpoint: Complete control of vertigo or reduction in vertigo attack frequency. Planned start Dec 2016; status: not yet recruiting.